Dolby Laboratories, Inc.DLBNYSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank49
3Y CAGR-65.4%
5Y CAGR-54.5%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-65.4%/yr
vs +127.8%/yr prior
5Y CAGR
-54.5%/yr
Recent deceleration
Acceleration
-193.2pp
Decelerating
Percentile
P49
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 7.69% |
| Q3 2025 | 8.33% |
| Q2 2025 | -49.47% |
| Q1 2025 | 33.80% |
| Q4 2024 | 16.39% |
| Q3 2024 | 52.50% |
| Q2 2024 | -60.78% |
| Q1 2024 | 45.71% |
| Q4 2023 | 600.00% |
| Q3 2023 | -41.18% |
| Q2 2023 | -83.00% |
| Q1 2023 | 20.48% |
| Q4 2022 | 186.21% |
| Q3 2022 | -27.50% |
| Q3 2022 | 11.11% |
| Q2 2022 | -54.43% |
| Q4 2021 | 79.55% |
| Q3 2021 | -18.52% |
| Q2 2021 | -28.00% |
| Q1 2021 | -44.03% |
| Q4 2020 | 396.30% |
| Q3 2020 | -59.70% |
| Q2 2020 | -23.86% |
| Q1 2020 | 79.59% |
| Q4 2019 | 11.36% |
| Q3 2019 | 12.82% |
| Q2 2019 | -45.83% |
| Q1 2019 | -25.00% |
| Q4 2018 | 100.00% |
| Q3 2018 | -40.00% |
| Q2 2018 | 17.65% |
| Q1 2018 | 185.00% |
| Q4 2017 | -480.95% |
| Q3 2017 | -72.00% |
| Q2 2017 | 50.00% |
| Q1 2017 | -5.66% |
| Q4 2016 | 120.83% |
| Q3 2016 | -61.90% |
| Q3 2016 | -5.97% |
| Q2 2016 | 116.13% |